Last 12 months
Inside the activity.
0 purchase rows · 64 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 24 |
| Dec 2025 | 0 | 6 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 12 |
| Mar 2026 | 0 | 13 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 4 |
| Sep 2026 | 0 | 3 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 19, 2017 Filed Feb 22, 2017 23:53 UTC |
Horton AmyVP, Chief Accounting Officer
|
Tax withholdingCommon Stock | 1,745 | $17.25 | $30,101.25 |
DisclosureSEC source: 0000784199-17-000017 · certent-form4.xml · nonDerivative · entry 1 Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,006 F1 · shares: These shares were withheld upon the vesting of restricted stock to pay tax withholding obligations. Read SEC document |
| February 19, 2017 Filed Feb 22, 2017 23:50 UTC |
Holloway Jean FVP, General Counsel
|
Tax withholdingCommon Stock | 2,212 | $17.25 | $38,157.00 |
DisclosureSEC source: 0000784199-17-000015 · certent-form4.xml · nonDerivative · entry 3 Holloway Jean F · CIK 0001540065 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,617 F1 · shares: These shares were withheld upon the vesting of restricted stock to pay tax withholding obligations. Read SEC document |
| February 19, 2017 Filed Feb 22, 2017 23:50 UTC |
Holloway Jean FVP, General Counsel
|
GrantCommon Stock | 13,262 | $17.25 | $228,769.50 |
DisclosureSEC source: 0000784199-17-000015 · certent-form4.xml · nonDerivative · entry 2 Holloway Jean F · CIK 0001540065 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,829 F2 · shares: Represents performance stock units granted on February 19, 2016 and earned at approximately 142.2% of target based on 2016 adjusted EBITDA. Fifty percent (50%) were issued on February 19, 2017. The remaining shares earned in connection with the February 2016 grant will vest and be issued as follows: 50% on 02/19/2018, and 50% on 02/19/2019, assuming continued employment on the relevant vesting date. Read SEC document |
| February 19, 2017 Filed Feb 22, 2017 23:50 UTC |
Holloway Jean FVP, General Counsel
|
Tax withholdingCommon Stock | 784 | $17.25 | $13,524.00 |
DisclosureSEC source: 0000784199-17-000015 · certent-form4.xml · nonDerivative · entry 1 Holloway Jean F · CIK 0001540065 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,567 F1 · shares: These shares were withheld upon the vesting of restricted stock to pay tax withholding obligations. Read SEC document |
| February 19, 2017 Filed Feb 22, 2017 23:39 UTC |
Gale David CVP, Research & Development
|
Tax withholdingCommon Stock | 1,745 | $17.25 | $30,101.25 |
DisclosureSEC source: 0000784199-17-000013 · certent-form4.xml · nonDerivative · entry 3 Gale David C · CIK 0001539068 · VP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,109 F1 · shares: These shares were withheld upon the vesting of restricted stock to pay tax withholding obligations. Read SEC document |
| February 19, 2017 Filed Feb 22, 2017 23:39 UTC |
Gale David CVP, Research & Development
|
GrantCommon Stock | 10,471 | $17.25 | $180,624.75 |
DisclosureSEC source: 0000784199-17-000013 · certent-form4.xml · nonDerivative · entry 2 Gale David C · CIK 0001539068 · VP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,854 F2 · shares: Represents performance stock units granted on February 19, 2016 and earned at approximately 142.2% of target based on 2016 adjusted EBITDA. Fifty percent (50%) were issued on February 19, 2017. The remaining shares earned in connection with the February 2016 grant will vest and be issued as follows: 50% on 02/19/2018, and 50% on 02/19/2019, assuming continued employment on the relevant vesting date. Read SEC document |
| February 19, 2017 Filed Feb 22, 2017 23:39 UTC |
Gale David CVP, Research & Development
|
Tax withholdingCommon Stock | 777 | $17.25 | $13,403.25 |
DisclosureSEC source: 0000784199-17-000013 · certent-form4.xml · nonDerivative · entry 1 Gale David C · CIK 0001539068 · VP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,383 F1 · shares: These shares were withheld upon the vesting of restricted stock to pay tax withholding obligations. Read SEC document |
| February 19, 2017 Filed Feb 22, 2017 23:36 UTC |
Davis John ESenior VP, Global Sales
|
Tax withholdingCommon Stock | 2,212 | $17.25 | $38,157.00 |
DisclosureSEC source: 0000784199-17-000011 · certent-form4.xml · nonDerivative · entry 2 Davis John E · CIK 0001653206 · Senior VP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,364 F2 · shares: These shares were withheld upon the vesting of restricted stock to pay tax withholding obligations. Read SEC document |
| February 19, 2017 Filed Feb 22, 2017 23:36 UTC |
Davis John ESenior VP, Global Sales
|
GrantCommon Stock | 13,262 | $17.25 | $228,769.50 |
DisclosureSEC source: 0000784199-17-000011 · certent-form4.xml · nonDerivative · entry 1 Davis John E · CIK 0001653206 · Senior VP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,576 F1 · shares: Represents performance stock units granted on February 19, 2016 and earned at approximately 142.2% of target based on 2016 adjusted EBITDA. Fifty percent (50%) were issued on February 19, 2017. The remaining shares earned in connection with the February 2016 grant will vest and be issued as follows: 50% on 02/19/2018, and 50% on 02/19/2019, assuming continued employment on the relevant vesting date. Read SEC document |
| February 19, 2017 Filed Feb 22, 2017 23:33 UTC |
Capps Scott BVP, Clinical Research
|
Tax withholdingCommon Stock | 785 | $17.25 | $13,541.25 |
DisclosureSEC source: 0000784199-17-000009 · certent-form4.xml · nonDerivative · entry 3 Capps Scott B · CIK 0001409753 · VP, Clinical Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,642 F1 · shares: These shares were withheld upon the vesting of restricted stock to pay tax withholding obligations. Read SEC document |
| February 19, 2017 Filed Feb 22, 2017 23:33 UTC |
Capps Scott BVP, Clinical Research
|
GrantCommon Stock | 10,471 | $17.25 | $180,624.75 |
DisclosureSEC source: 0000784199-17-000009 · certent-form4.xml · nonDerivative · entry 2 Capps Scott B · CIK 0001409753 · VP, Clinical Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,113 F2 · shares: Represents performance stock units granted on February 19, 2016 and earned at approximately 142.2% of target based on 2016 adjusted EBITDA. Fifty percent (50%) were issued on February 19, 2017. The remaining shares earned in connection with the February 2016 grant will vest and be issued as follows: 50% on 02/19/2018, and 50% on 02/19/2019, assuming continued employment on the relevant vesting date. Read SEC document |
| February 19, 2017 Filed Feb 22, 2017 23:33 UTC |
Capps Scott BVP, Clinical Research
|
Tax withholdingCommon Stock | 1,747 | $17.25 | $30,135.75 |
DisclosureSEC source: 0000784199-17-000009 · certent-form4.xml · nonDerivative · entry 1 Capps Scott B · CIK 0001409753 · VP, Clinical Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,366 F1 · shares: These shares were withheld upon the vesting of restricted stock to pay tax withholding obligations. Read SEC document |
| January 03, 2017 Filed Jan 5, 2017 21:58 UTC |
Benson JamesDirector
|
Disposition to issuerCommon Stock | 2,000 | $19.10 | $38,200.00 |
DisclosureSEC source: 0000784199-17-000003 · certent-form4.xml · nonDerivative · entry 1 Benson James · CIK 0001308620 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,086 F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on September 16, 2016. F2 · price: Reflects the weighted price of $19.10 the shares were sold. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at this price. Read SEC document |
| December 31, 2016 Filed Jul 11, 2017 12:58 UTC |
Holloway Jean FVP, General Counsel
|
GrantStock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $10.20 | $0.00 |
DisclosureSEC source: 0000784199-17-000074 · certent-form5.xml · derivative · entry 7 Holloway Jean F · CIK 0001540065 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,000 shares Expires 2016-12-31 Read SEC document |
| December 31, 2016 Filed Jul 11, 2017 12:58 UTC |
Holloway Jean FVP, General Counsel
|
GrantStock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $10.20 | $0.00 |
DisclosureSEC source: 0000784199-17-000074 · certent-form5.xml · derivative · entry 6 Holloway Jean F · CIK 0001540065 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Underlying: Common Stock · 1,000 shares Expires 2016-12-31 Read SEC document |
| December 31, 2016 Filed Jul 11, 2017 12:58 UTC |
Holloway Jean FVP, General Counsel
|
Exercise / conversionCommon Stock | 1,000 | $10.20 | $10,200.00 |
DisclosureSEC source: 0000784199-17-000074 · certent-form5.xml · nonDerivative · entry 2 Holloway Jean F · CIK 0001540065 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,358 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These shares were acquired pursuant to CryoLife Inc.'s Employee Stock Purchase Plan (ESPP). The shares were acquired in transactions exempt from Section 16b-3. Read SEC document |
| December 31, 2016 Filed Jul 11, 2017 12:56 UTC |
Davis John ESenior VP, Global Sales
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $10.20 | $0.00 |
DisclosureSEC source: 0000784199-17-000072 · certent-form5.xml · derivative · entry 4 Davis John E · CIK 0001653206 · Senior VP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,000 shares Expires 2016-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 31, 2016 Filed Jul 11, 2017 12:56 UTC |
Davis John ESenior VP, Global Sales
|
GrantStock Option(Right to Buy) · Derivative | 2,000 | $0.00 Strike: $10.20 | $0.00 |
DisclosureSEC source: 0000784199-17-000072 · certent-form5.xml · derivative · entry 3 Davis John E · CIK 0001653206 · Senior VP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Underlying: Common Stock · 2,000 shares Expires 2016-12-31 Read SEC document |
| December 31, 2016 Filed Jul 11, 2017 12:56 UTC |
Davis John ESenior VP, Global Sales
|
Exercise / conversionCommon Stock | 2,000 | $10.20 | $20,400.00 |
DisclosureSEC source: 0000784199-17-000072 · certent-form5.xml · nonDerivative · entry 1 Davis John E · CIK 0001653206 · Senior VP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,586 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These shares were acquired pursuant to CryoLife Inc.'s Employee Stock Purchase Plan (ESPP). The shares were acquired in transactions exempt from Section 16b-3. Read SEC document |
| November 23, 2016 Filed Nov 28, 2016 21:45 UTC |
RONALD C ELKINSDirector
|
Disposition to issuerCommon Stock | 2,000 | $20.00 | $40,000.00 |
DisclosureSEC source: 0000784199-16-000320 · certent-form4.xml · nonDerivative · entry 1 RONALD C ELKINS · CIK 0001016744 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,586 F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on September 16, 2016. F2 · price: Reflects weighted average price. Price was $20 for all shares. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| November 14, 2016 Filed Nov 16, 2016 21:48 UTC |
RONALD C ELKINSDirector
|
Disposition to issuerCommon Stock | 2,000 | $18.65 | $37,302.00 |
DisclosureSEC source: 0000784199-16-000315 · certent-form4.xml · nonDerivative · entry 1 RONALD C ELKINS · CIK 0001016744 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,586 F1 · price: Reflects weighted average price. Price was $18.651 for all shares. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| October 31, 2016 Filed Nov 1, 2016 20:32 UTC |
Benson JamesDirector
|
Disposition to issuerCommon Stock | 2,000 | $16.75 | $33,500.60 |
DisclosureSEC source: 0000784199-16-000308 · certent-form4.xml · nonDerivative · entry 1 Benson James · CIK 0001308620 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,086 F1 · shares: The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on September 16, 2016. F2 · price: Reflects the weighted price of $16.75038 the shares were sold. The range was from $16.55 to $17. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at this price. Read SEC document |
| September 20, 2016 Filed Sep 22, 2016 21:00 UTC |
RONALD C ELKINSDirector
|
Disposition to issuerCommon Stock | 1,000 | $18.00 | $18,000.00 |
DisclosureSEC source: 0000784199-16-000303 · certent-form4.xml · nonDerivative · entry 1 RONALD C ELKINS · CIK 0001016744 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,586 F1 · price: Reflects weighted average price. Price was $18 for all shares. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| September 15, 2016 Filed Sep 16, 2016 20:31 UTC |
McCall Ronald DDirector
|
Disposition to issuerCommon Stock | 3,000 | $17.54 | $52,630.80 |
DisclosureSEC source: 0000784199-16-000301 · certent-form4.xml · nonDerivative · entry 1 McCall Ronald D · CIK 0001016766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,248 F1 · price: Reflects the weighted price of $17.5436 the shares were sold. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at this price. Read SEC document |
| September 13, 2016 Filed Sep 13, 2016 22:06 UTC |
Horton AmyVP, Chief Accounting Officer
|
Disposition to issuerCommon Stock | 3,000 | $17.47 | $52,410.00 |
DisclosureSEC source: 0000784199-16-000282 · certent-form4.xml · nonDerivative · entry 1 Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,798 F1 · price: Reflects weighted average price. Range was $17.47 for all shares. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| September 13, 2016 Filed Sep 15, 2016 21:00 UTC |
Matthews William RobertSenior VP, Operations, Quality
|
GrantCommon Stock | 1,156 | $17.39 | $20,099.83 |
DisclosureSEC source: 0000784199-16-000299 · certent-form4.xml · nonDerivative · entry 1 Matthews William Robert · CIK 0001649291 · Senior VP, Operations, Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,970 F1 · price: Reflects the price of $17.3874 the shares were purchased on the open market. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at this price. Read SEC document |
| September 12, 2016 Filed Sep 13, 2016 22:07 UTC |
LEE DAVID ASHLEYExecutive VP, COO & CFO
|
Exercise / conversionStock Option · Derivative | 1,500 | $0.00 Strike: $7.01 | $0.00 |
DisclosureSEC source: 0000784199-16-000285 · certent-form4.xml · derivative · entry 8 LEE DAVID ASHLEY · CIK 0001112830 · Executive VP, COO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,500 Underlying: Common Stock · 1,500 shares Expires 2017-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 2/22/2011 Read SEC document |
| September 12, 2016 Filed Sep 13, 2016 22:07 UTC |
LEE DAVID ASHLEYExecutive VP, COO & CFO
|
Exercise / conversionStock Option · Derivative | 2,986 | $0.00 Strike: $7.01 | $0.00 |
DisclosureSEC source: 0000784199-16-000285 · certent-form4.xml · derivative · entry 7 LEE DAVID ASHLEY · CIK 0001112830 · Executive VP, COO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,986 Underlying: Common Stock · 2,986 shares Expires 2017-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 2/22/2011 Read SEC document |
| September 12, 2016 Filed Sep 13, 2016 22:07 UTC |
LEE DAVID ASHLEYExecutive VP, COO & CFO
|
Exercise / conversionCommon Stock | 1,500 | $7.01 | $10,515.00 |
DisclosureSEC source: 0000784199-16-000285 · certent-form4.xml · nonDerivative · entry 5 LEE DAVID ASHLEY · CIK 0001112830 · Executive VP, COO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 274,112 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 12, 2016 Filed Sep 13, 2016 22:07 UTC |
LEE DAVID ASHLEYExecutive VP, COO & CFO
|
Disposition to issuerCommon Stock | 2,986 | $17.29 | $51,629.43 |
DisclosureSEC source: 0000784199-16-000285 · certent-form4.xml · nonDerivative · entry 4 LEE DAVID ASHLEY · CIK 0001112830 · Executive VP, COO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 272,612 F2 · price: Reflects weighted average price. Range was $17.03 to $17.50. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| September 12, 2016 Filed Sep 13, 2016 22:07 UTC |
LEE DAVID ASHLEYExecutive VP, COO & CFO
|
Exercise / conversionCommon Stock | 2,986 | $7.01 | $20,931.86 |
DisclosureSEC source: 0000784199-16-000285 · certent-form4.xml · nonDerivative · entry 3 LEE DAVID ASHLEY · CIK 0001112830 · Executive VP, COO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 275,598 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 12, 2016 Filed Sep 14, 2016 21:30 UTC |
Holloway Jean FVP, General Counsel
|
Exercise / conversionStock Option · Derivative | 3,000 | $0.00 Strike: $9.64 | $0.00 |
DisclosureSEC source: 0000784199-16-000294 · certent-form4.xml · derivative · entry 3 Holloway Jean F · CIK 0001540065 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Underlying: Common Stock · 3,000 shares Expires 2022-09-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 9/10/2016 Read SEC document |
| September 12, 2016 Filed Sep 14, 2016 21:30 UTC |
Holloway Jean FVP, General Counsel
|
Disposition to issuerCommon Stock | 3,000 | $17.03 | $51,081.30 |
DisclosureSEC source: 0000784199-16-000294 · certent-form4.xml · nonDerivative · entry 2 Holloway Jean F · CIK 0001540065 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,351 F1 · price: Reflects the price of $17.0271 the shares were sold. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at this price. Read SEC document |
| September 12, 2016 Filed Sep 14, 2016 21:30 UTC |
Holloway Jean FVP, General Counsel
|
Exercise / conversionCommon Stock | 3,000 | $9.64 | $28,920.00 |
DisclosureSEC source: 0000784199-16-000294 · certent-form4.xml · nonDerivative · entry 1 Holloway Jean F · CIK 0001540065 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,351 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 12, 2016 Filed Sep 14, 2016 21:27 UTC |
MORGAN HARVEYDirector
|
GiftCommon Stock | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-16-000291 · certent-form4.xml · nonDerivative · entry 2 MORGAN HARVEY · CIK 0001137972 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Shares owned by spouse Disclosed balance after: 36,300 F2 · shares: 2000 shares were gifted by the reporting person's spouse to a charity Read SEC document |
| September 12, 2016 Filed Sep 14, 2016 21:27 UTC |
MORGAN HARVEYDirector
|
GiftCommon Stock | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-16-000291 · certent-form4.xml · nonDerivative · entry 1 MORGAN HARVEY · CIK 0001137972 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,036 F1 · shares: 2000 shares were gifted by the reporting person to a charity Read SEC document |
| September 12, 2016 Filed Sep 14, 2016 21:19 UTC |
RONALD C ELKINSDirector
|
Disposition to issuerCommon Stock | 1,000 | $17.25 | $17,248.60 |
DisclosureSEC source: 0000784199-16-000287 · certent-form4.xml · nonDerivative · entry 1 RONALD C ELKINS · CIK 0001016744 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,586 F1 · price: Reflects average price. Range was $17.24 to $17.255. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| September 12, 2016 Filed Sep 14, 2016 21:21 UTC |
Gale David CVP, Research & Development
|
Exercise / conversionStock Option · Derivative | 3,000 | $0.00 Strike: $7.01 | $0.00 |
DisclosureSEC source: 0000784199-16-000289 · certent-form4.xml · derivative · entry 3 Gale David C · CIK 0001539068 · VP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Underlying: Common Stock · 3,000 shares Expires 2017-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 2/22/2011 Read SEC document |
| September 12, 2016 Filed Sep 14, 2016 21:21 UTC |
Gale David CVP, Research & Development
|
Disposition to issuerCommon Stock | 3,000 | $17.49 | $52,458.60 |
DisclosureSEC source: 0000784199-16-000289 · certent-form4.xml · nonDerivative · entry 2 Gale David C · CIK 0001539068 · VP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,190 F2 · price: Reflects the price of $17.4862 the shares were sold. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at this price. Read SEC document |
| September 12, 2016 Filed Sep 14, 2016 21:21 UTC |
Gale David CVP, Research & Development
|
Exercise / conversionCommon Stock | 3,000 | $7.01 | $21,030.00 |
DisclosureSEC source: 0000784199-16-000289 · certent-form4.xml · nonDerivative · entry 1 Gale David C · CIK 0001539068 · VP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,190 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Balance reflects a 416 share correction that should have been added to the last total. Read SEC document |
| September 09, 2016 Filed Sep 13, 2016 22:07 UTC |
LEE DAVID ASHLEYExecutive VP, COO & CFO
|
Exercise / conversionStock Option · Derivative | 28,847 | $0.00 Strike: $7.01 | $0.00 |
DisclosureSEC source: 0000784199-16-000285 · certent-form4.xml · derivative · entry 6 LEE DAVID ASHLEY · CIK 0001112830 · Executive VP, COO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,847 Underlying: Common Stock · 28,847 shares Expires 2017-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 2/22/2011 Read SEC document |
| September 09, 2016 Filed Sep 13, 2016 22:07 UTC |
LEE DAVID ASHLEYExecutive VP, COO & CFO
|
Exercise / conversionCommon Stock | 28,847 | $7.01 | $202,217.47 |
DisclosureSEC source: 0000784199-16-000285 · certent-form4.xml · nonDerivative · entry 2 LEE DAVID ASHLEY · CIK 0001112830 · Executive VP, COO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 301,459 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 09, 2016 Filed Sep 13, 2016 22:07 UTC |
LEE DAVID ASHLEYExecutive VP, COO & CFO
|
Disposition to issuerCommon Stock | 28,847 | $17.26 | $498,034.80 |
DisclosureSEC source: 0000784199-16-000285 · certent-form4.xml · nonDerivative · entry 1 LEE DAVID ASHLEY · CIK 0001112830 · Executive VP, COO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 272,612 F1 · price: Reflects weighted average price. Range was $17.215 to $17.37. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| September 09, 2016 Filed Sep 13, 2016 22:06 UTC |
Horton AmyVP, Chief Accounting Officer
|
Disposition to issuerCommon Stock | 2,000 | $17.53 | $35,056.60 |
DisclosureSEC source: 0000784199-16-000282 · certent-form4.xml · nonDerivative · entry 3 Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,548 F3 · price: Reflects weighted average price. Range was $17.52 to $17.5366. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| September 09, 2016 Filed Sep 13, 2016 22:06 UTC |
Horton AmyVP, Chief Accounting Officer
|
Disposition to issuerCommon Stock | 750 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-16-000282 · certent-form4.xml · nonDerivative · entry 2 Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,798 F2 · shares: 750 shares were gifted by the reporting person to a charity Read SEC document |
| September 09, 2016 Filed Sep 13, 2016 22:04 UTC |
Benson JamesDirector
|
Disposition to issuerCommon Stock | 10,000 | $17.18 | $171,800.00 |
DisclosureSEC source: 0000784199-16-000280 · certent-form4.xml · nonDerivative · entry 1 Benson James · CIK 0001308620 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,086 F1 · shares: Reflects weighted average price. Range was $17.47 for all shares. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F1 · price: Reflects weighted average price. Range was $17.47 for all shares. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| June 30, 2016 Filed Jul 11, 2017 12:58 UTC |
Holloway Jean FVP, General Counsel
|
GrantStock Option(Right to Buy) · Derivative | 1,205 | $0.00 Strike: $9.16 | $0.00 |
DisclosureSEC source: 0000784199-17-000074 · certent-form5.xml · derivative · entry 5 Holloway Jean F · CIK 0001540065 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,205 shares Expires 2016-06-30 Read SEC document |
| June 30, 2016 Filed Jul 11, 2017 12:58 UTC |
Holloway Jean FVP, General Counsel
|
GrantStock Option (Right to Buy) · Derivative | 1,205 | $0.00 Strike: $9.16 | $0.00 |
DisclosureSEC source: 0000784199-17-000074 · certent-form5.xml · derivative · entry 4 Holloway Jean F · CIK 0001540065 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,205 Underlying: Common Stock · 1,205 shares Expires 2016-06-30 Read SEC document |
| June 30, 2016 Filed Jul 11, 2017 12:58 UTC |
Holloway Jean FVP, General Counsel
|
Exercise / conversionCommon Stock | 1,205 | $9.16 | $11,041.42 |
DisclosureSEC source: 0000784199-17-000074 · certent-form5.xml · nonDerivative · entry 1 Holloway Jean F · CIK 0001540065 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,358 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These shares were acquired pursuant to CryoLife Inc.'s Employee Stock Purchase Plan (ESPP). The shares were acquired in transactions exempt from Section 16b-3. Read SEC document |
| February 19, 2016 Filed Sep 6, 2017 21:40 UTC Amendment |
Mackin James PPresident & CEO
|
GrantCommon Stock | 42,484 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-17-000080 · certent-form4a.xml · nonDerivative · entry 1 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 323,316 F1 · balance_after: In a Form 4 filed on February 23, 2016, Reporting Person over reported the total number of shares beneficially owned by a de minimus number of shares. As a result, such additional shares were reflected in the post-transaction amounts in column 5 of that and all subsequent Forms 4. Beneficially owned shares are hereby updated in column 5 on this Form 4 to exclude such previously-added shares. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.